Physician profile
Ajanta De
NPI 1336198878
$9,843.43
in general payments reported to CMS, 2019-2025
27 companies · $1,940 in 2025
The $1,940 reported for 2025 was more than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,954 · 2020: $413 · 2021: $519 · 2022: $1,106 · 2023: $1,783 · 2024: $128 · 2025: $1,940.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $2,477 · Food and Beverage: $1,374.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,476.85 |
| Food and Beverage | $1,374.47 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Terumo Medical Corporation | $3,500.00 | 2019 | |
| Abbott Laboratories | $2,391.60 | 2019-2025 | Triclip, Diamondback Coronary, Assurity |
| Medical Device Business Services, INC. | $1,194.14 | 2023 | Carto 3 |
| Organogenesis INC. | $472.34 | 2021-2024 | Puraply |
| Janssen Pharmaceuticals, INC | $364.04 | 2019-2022 | |
| Abiomed | $293.99 | 2025 | |
| Amgen INC. | $181.97 | 2019-2022 | |
| Integra Lifesciences Corporation | $145.41 | 2022 | |
| Bardy Diagnostics, INC. | $144.93 | 2020-2022 | |
| Biosense Webster, INC. | $139.37 | 2023 | |
| Medtronic, INC. | $139.24 | 2022-2023 | Azure Xt Dr Mri Surescan |
| Medtronic Vascular, INC. | $113.12 | 2019 | |
| Baxter Healthcare | $97.26 | 2023-2025 | Hillrom - Cardiac Ambulatory Monitor, Hillrom - Carnation Ambulatory Monitor |
| Smith+Nephew, INC. | $94.57 | 2024-2025 | Grafix, Collagenase Santyl |
| Endologix LLC | $93.56 | 2023 |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Esperion Therapeutics, INC. | $74.47 | 2020-2021 | |
| E.R. Squibb & Sons, L.L.C. | $67.17 | 2021-2022 | |
| Astrazeneca Pharmaceuticals Lp | $56.88 | 2019 | |
| Bard Peripheral Vascular, INC. | $52.18 | 2023 | Venclose Maven Catheter |
| Astellas Pharma US INC | $45.11 | 2020 | |
| Amarin Pharma, INC. | $42.94 | 2020-2021 | |
| Sirtex Medical INC | $37.81 | 2024 | Sir-Spheres Microspheres |
| Angiodynamics, INC. | $26.22 | 2021 | |
| Biotronik INC. | $22.74 | 2019 | |
| Pfizer INC. | $19.10 | 2022 | |
| Boston Scientific Corporation | $16.82 | 2022 | |
| Kiniksa Pharmaceuticals, Ltd. | $16.45 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ajanta De listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.